Dongsung Pharm (002210) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.104x

Based on the latest financial reports, Dongsung Pharm (002210) has a cash flow conversion efficiency ratio of 0.104x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.20 Billion ≈ $2.85 Million USD) by net assets (₩40.55 Billion ≈ $27.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002210 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Dongsung Pharm - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Dongsung Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Dongsung Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dongsung Pharm ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Western Mines Group Ltd AU:WMG	0.019x
Marvel Gold Ltd AU:MVL	-0.291x
BIORETEC OY F:0TN	N/A
Priceworth International Bhd KLSE:7123	-0.039x
Arcure SA PA:ALCUR	0.282x
HM Inwest S.A. WAR:HMI	0.164x
Kiang Huat Sea Gull Trading Frozen Food Public Company Limited BK:CHOTI	0.084x
Saray Matbaacilik Kagitcilik Kirtasiyecilik Ticaret ve Sanayi AS IS:SAMAT	-0.082x

Annual Cash Flow Conversion Efficiency for Dongsung Pharm (2008–2024)

The table below shows the annual cash flow conversion efficiency of Dongsung Pharm from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see Dongsung Pharm (002210) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩55.18 Billion ≈ $37.39 Million	₩-9.94 Billion ≈ $-6.74 Million	-0.180x	-67.06%
2023-12-31	₩39.80 Billion ≈ $26.97 Million	₩-4.29 Billion ≈ $-2.91 Million	-0.108x	-18.93%
2022-12-31	₩42.81 Billion ≈ $29.01 Million	₩-3.88 Billion ≈ $-2.63 Million	-0.091x	-53.08%
2021-12-31	₩46.44 Billion ≈ $31.47 Million	₩-2.75 Billion ≈ $-1.86 Million	-0.059x	-164.99%
2020-12-31	₩54.95 Billion ≈ $37.24 Million	₩5.01 Billion ≈ $3.40 Million	0.091x	+176.94%
2019-12-31	₩70.10 Billion ≈ $47.50 Million	₩-8.31 Billion ≈ $-5.63 Million	-0.118x	-588.87%
2018-12-31	₩57.48 Billion ≈ $38.96 Million	₩1.39 Billion ≈ $944.20K	0.024x	-13.40%
2017-12-31	₩64.27 Billion ≈ $43.56 Million	₩1.80 Billion ≈ $1.22 Million	0.028x	+146.55%
2016-12-31	₩55.62 Billion ≈ $37.69 Million	₩-3.34 Billion ≈ $-2.27 Million	-0.060x	-36.94%
2011-12-31	₩60.20 Billion ≈ $40.80 Million	₩-2.64 Billion ≈ $-1.79 Million	-0.044x	-170.43%
2010-12-31	₩59.10 Billion ≈ $40.05 Million	₩3.68 Billion ≈ $2.50 Million	0.062x	+184.40%
2009-12-31	₩67.97 Billion ≈ $46.06 Million	₩-5.02 Billion ≈ $-3.40 Million	-0.074x	-1271.65%
2008-12-31	₩67.82 Billion ≈ $45.96 Million	₩-365.26 Million ≈ $-247.53K	-0.005x	--

About Dongsung Pharm

KO:002210 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$16.09 Million

₩23.75 Billion KRW

Market Cap Rank

#25804 Global

#1883 in Korea

Share Price

₩973.00

Change (1 day)

+0.00%

52-Week Range

₩973.00 - ₩973.00

All Time High

₩45800.00